These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 18569375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients.
    Achour M, Kahla S, Zeghal D, Kochbati L, Mongi M, Zouari F, Oueslati R.
    Viral Immunol; 2009 Feb; 22(1):7-16. PubMed ID: 19210223
    [Abstract] [Full Text] [Related]

  • 4. Serological study in Tunisian cervical cancer patients.
    Achour M, Kochbati L, Zeghal D, Kahla S, Maalej M, Zouari F, Oueslati R.
    Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18.
    Layman H, Rickert KW, Wilson S, Aksyuk AA, Dunty JM, Natrakul D, Swaminathan N, DelNagro CJ.
    PLoS One; 2020 Jul; 15(3):e0229672. PubMed ID: 32214362
    [Abstract] [Full Text] [Related]

  • 6. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A, Gómez-Lim MA, Weiss-Steider B, la Rosa GP, Hernández-Montes J, Pérez-Saldaña K, Tapia-Guerrero YS, Toledo-Guzmán ME, Santiago-Osorio E, Sanchez-Peña HI, Mora-García Mde L.
    Virol J; 2011 Feb 09; 8():59. PubMed ID: 21306638
    [Abstract] [Full Text] [Related]

  • 7. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y, Choi JW, Kim HJ, Eddouzi J, Kim SC, Ju W, Kim YH, Kim HJ.
    Cancer Med; 2018 Nov 09; 7(11):5655-5664. PubMed ID: 30353680
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
    Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    J Virol; 2009 Jul 09; 83(13):6779-89. PubMed ID: 19386711
    [Abstract] [Full Text] [Related]

  • 9. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
    Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E, Eschenbach D, Zimmer H, Heilig B, Kopitz J, Pawlita M, Doeberitz Mv, Wentzensen N.
    Int J Cancer; 2008 Dec 01; 123(11):2626-31. PubMed ID: 18785210
    [Abstract] [Full Text] [Related]

  • 10. An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.
    de Vos van Steenwijk PJ, Heusinkveld M, Ramwadhdoebe TH, Löwik MJ, van der Hulst JM, Goedemans R, Piersma SJ, Kenter GG, van der Burg SH.
    Cancer Res; 2010 Apr 01; 70(7):2707-17. PubMed ID: 20233872
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K, Kisseljov F, Sacharova O, Shaichaev G, Semjonova L, Pavlova L, Pawlita M.
    Int J Cancer; 2000 Feb 01; 85(3):313-8. PubMed ID: 10652419
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer.
    Hasan Y, Furtado L, Tergas A, Lee N, Brooks R, McCall A, Golden D, Jolly S, Fleming G, Morrow M, Kraynyak K, Sylvester A, Arif F, Levin M, Schwartz D, Boyer J, Skolnik J, Esser M, Kumar R, Bagarazzi M, Weichselbaum R, Spiotto M.
    Int J Radiat Oncol Biol Phys; 2020 Jul 01; 107(3):487-498. PubMed ID: 32151670
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
    Liu JH, Lu ZT, Wang GL, Zhou WQ, Liu C, Yang LX, Sun ZR, Ruan Q.
    Infect Genet Evol; 2012 Oct 01; 12(7):1466-72. PubMed ID: 22659102
    [Abstract] [Full Text] [Related]

  • 18. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS, Park DC, Kim CJ, Ahn HK, Um SJ, Park SN, Kim SJ, Namkoong SE.
    Gynecol Oncol; 1998 Apr 01; 69(1):47-55. PubMed ID: 9570998
    [Abstract] [Full Text] [Related]

  • 19. Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women.
    Ramezani A, Aghakhani A, Soleymani S, Bavand A, Bolhassani A.
    BMC Infect Dis; 2019 Feb 12; 19(1):142. PubMed ID: 30755156
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
    Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, Sharma R, Batra S, Das BC.
    J Clin Microbiol; 2008 Mar 12; 46(3):1060-6. PubMed ID: 18199779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.